PURPOSE: Ocular complications related to Stevens-Johnson Syndrome (SJS)-Toxic Epidermal Necrolysis (TEN) may persist and progress after resolution of systemic disease. This is thought to be related in part to persistent ocular innate-immune signaling. In this study, our aim was to characterize infiltrative conjunctival cellular profiles during acute (<12 months) and chronic (>12 months) disease. METHODS: Consecutive patients presenting with SJS-TEN over a 12-month period were followed for 1 year. Detailed clinical examination and conjunctival impression cell recovery was analyzed by flow cytometry for the presence of intraepithelial leukocytes and compared with healthy controls (n = 21). RESULTS: Ten patients were recruited of whom six had acute disease and five were classified as TEN (SCORTEN = 1, n = 4). Conjunctival inflammation was graded as absent/mild in a total of nine patients; but despite this, evidence of fornix shrinkage was observed in nine subjects. This inversely correlated with disease duration (P < 0.05). A reduction in percentage of CD8αβ(+) T cells compared with controls (80% vs. 57%; P < 0.01) was associated with a corresponding increase in the number/percentage of CD45(INT)CD11b(+)CD16(+)CD14(-) neutrophils (186 vs. 3.4, P < 0.01, 31% vs. 0.8%, P < 0.001). Neutrophils inversely correlated with disease duration (r = -0.71, P = 0.03), yet there was no absolute change in the CD8αβ(+) or neutrophil populations during the study period (P = 1.0). CONCLUSIONS: These data highlight that a neutrophilic infiltrate is present in mildly inflamed or clinically quiescent conjunctival mucosa in patients with ocular SJS-TEN, where neutrophil numbers inversely correlate with disease duration. Neutrophil persistence endorses the hypothesis of an unresolved innate-inflammatory process that might account for disease progression.
PURPOSE: Ocular complications related to Stevens-Johnson Syndrome (SJS)-Toxic Epidermal Necrolysis (TEN) may persist and progress after resolution of systemic disease. This is thought to be related in part to persistent ocular innate-immune signaling. In this study, our aim was to characterize infiltrative conjunctival cellular profiles during acute (<12 months) and chronic (>12 months) disease. METHODS: Consecutive patients presenting with SJS-TEN over a 12-month period were followed for 1 year. Detailed clinical examination and conjunctival impression cell recovery was analyzed by flow cytometry for the presence of intraepithelial leukocytes and compared with healthy controls (n = 21). RESULTS: Ten patients were recruited of whom six had acute disease and five were classified as TEN (SCORTEN = 1, n = 4). Conjunctival inflammation was graded as absent/mild in a total of nine patients; but despite this, evidence of fornix shrinkage was observed in nine subjects. This inversely correlated with disease duration (P < 0.05). A reduction in percentage of CD8αβ(+) T cells compared with controls (80% vs. 57%; P < 0.01) was associated with a corresponding increase in the number/percentage of CD45(INT)CD11b(+)CD16(+)CD14(-) neutrophils (186 vs. 3.4, P < 0.01, 31% vs. 0.8%, P < 0.001). Neutrophils inversely correlated with disease duration (r = -0.71, P = 0.03), yet there was no absolute change in the CD8αβ(+) or neutrophil populations during the study period (P = 1.0). CONCLUSIONS: These data highlight that a neutrophilic infiltrate is present in mildly inflamed or clinically quiescent conjunctival mucosa in patients with ocular SJS-TEN, where neutrophil numbers inversely correlate with disease duration. Neutrophil persistence endorses the hypothesis of an unresolved innate-inflammatory process that might account for disease progression.
Authors: Adam M Quinn; Kimberly Brown; Brian K Bonish; Jonathan Curry; Kenneth B Gordon; James Sinacore; Richard Gamelli; Brian J Nickoloff Journal: Arch Dermatol Date: 2005-06
Authors: Jose Santiago López-García; Luis Rivas Jara; Carmen Isabel García-Lozano; Eduardo Conesa; Isabel Elosua de Juan; Juan Murube del Castillo Journal: Ophthalmology Date: 2010-09-29 Impact factor: 12.079
Authors: Jerry Y Niederkorn; Michael E Stern; Stephen C Pflugfelder; Cintia S De Paiva; Rosa M Corrales; Jianping Gao; Karyn Siemasko Journal: J Immunol Date: 2006-04-01 Impact factor: 5.422
Authors: Geraint P Williams; Valerie P J Saw; Tariq Saeed; Simon T Evans; Paul Cottrell; S John Curnow; Peter Nightingale; Saaeha Rauz Journal: Br J Ophthalmol Date: 2010-10-17 Impact factor: 4.638
Authors: Geraint P Williams; Annette Pachnio; Heather M Long; Saaeha Rauz; S John Curnow Journal: Invest Ophthalmol Vis Sci Date: 2014-11-13 Impact factor: 4.799
Authors: Marjan Farid; Anshu Agrawal; Daniel Fremgen; Jeremiah Tao; He Chuyi; Anthony B Nesburn; Lbachir BenMohamed Journal: Ocul Immunol Inflamm Date: 2014-12-23 Impact factor: 3.070
Authors: Loraine L W Chow; Alex L K Ng; Sharon S W Chow; Bonnie N K Choy; Kendrick C Shih; Ian Y H Wong; Johnny C Y Chan; Jimmy S M Lai Journal: Int Ophthalmol Date: 2017-05-25 Impact factor: 2.031
Authors: Geraint P Williams; Peter Nightingale; Sue Southworth; Alastair K O Denniston; Paul J Tomlins; Stephen Turner; John Hamburger; Simon J Bowman; S John Curnow; Saaeha Rauz Journal: Invest Ophthalmol Vis Sci Date: 2016-10-01 Impact factor: 4.799
Authors: Livia Rosa-Fernandes; Raquel Hora Barbosa; Maria Luiza B Dos Santos; Claudia B Angeli; Thiago P Silva; Rossana C N Melo; Gilberto Santos de Oliveira; Bernardo Lemos; Jennifer E Van Eyk; Martin R Larsen; Claudete Araújo Cardoso; Giuseppe Palmisano Journal: J Proteome Res Date: 2020-08-04 Impact factor: 4.466
Authors: Radhika Susarla; Lei Liu; Elizabeth A Walker; Iwona J Bujalska; Jawaher Alsalem; Geraint P Williams; Sreekanth Sreekantam; Angela E Taylor; Mohammad Tallouzi; H Susan Southworth; Philip I Murray; Graham R Wallace; Saaeha Rauz Journal: PLoS One Date: 2014-04-15 Impact factor: 3.240